Chimerix (CMRX) has had the highest return since February 24, 2025 by a small-cap US stock, returning 63.4%.
| ASSET | % RETURN |
|---|---|
Chimerix (CMRX) | 63.37% |
Organogenesis (ORGO) | 58.62% |
Owens & Minor (OMI) | 58.48% |
Porch (PRCH) | 51.61% |
Chromadex (CDXC) | 41.8% |
Heron Therapeuti (HRTX) | 38.15% |
Gaotu Techedu Inc DRC (GOTU) | 36.74% |
ECARX Holdings Inc Class A Ordinary shares (ECX) | 33.97% |
Clene (CLNNW) | 32.33% |
Willdan (WLDN) | 28.65% |
Bicara Therapeutics Inc Common Stock (BCAX) | 27.9% |
Middlesex Water (MSEX) | 25.86% |
EverQuote Inc Class A (EVER) | 24.07% |
Adapthealth (AHCO) | 23.58% |
Verastem (VSTM) | 23.24% |
Establishment Labs (ESTA) | 22.57% |
Falcon's Beyond Global, Inc Class A Common Stock (FBYD) | 21.37% |
Astronics (ATRO) | 21.34% |
Target Hospitality (TH) | 19.63% |
Neuronetics (STIM) | 19.58% |
AerSale (ASLE) | 19.25% |
Kalvista Pharmaceuticals (KALV) | 18.96% |
Tutor Perini (TPC) | 18.34% |
Tiptree (TIPT) | 18.14% |
Waldencast Acquisition (WALDW) | 17.48% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
